Answers are grounded in this paper and cite their sources.
This manuscript demonstrates a QbD framework to improve technology transfer efficiency in biologics, suggesting benefits for manufacturing processes.
Technology transfer from clients to contract development and manufacturing organizations is a complicated process and inclusion of scale-up and scale-down strategies brings additional complexity. These complexities can lead to extended development timelines and significant resource utilizations to meet regulatory compliance. This manuscript presents the implementation of Quality by Design (QbD) principles as a systematic framework to mitigate these challenges and improve technology transfer efficiency. Here I provide a strategic approach to integrate QbD across five key stages of technology transfer: Scope of Work Development, Information Transfer and Failure Mode and Effects Analysis, Technology Transfer and Pilot Runs, Pre-Production Activities, and cGMP Production. By adopting this QbD-driven methodology, companies can achieve more effective knowledge transfer, develop scalable and reproducible processes, and ensure consistent product quality in alignment with regulatory standards.
No takes yet. Share an insight, caveat, or question.
Dogan Ornek (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: